Park Ha Biological Technology is trading 5.47% up at $2.89, extending recent gains despite no clear company-specific announcement dated September 16, 2026 being identified.
- The stock closed at $2.74 on September 15, up from $2.60 on September 14.
- Available coverage centers on previously reported securities litigation and an earlier accounting-firm change.
- The broader Nasdaq is higher, while biotech-sector weakness conflicts with the move, leaving the catalyst unclear.